Title : Optimal timing and best antiretroviral regimen in treatment-naive HIV-infected individuals with advanced disease.

Pub. Date : 2007 Sep

PMID : 17713424






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Some cohort studies and randomized clinical trials support the use of efavirenz-based antiretroviral therapy for the treatment of advanced HIV-1-infected patients; however, recent randomized controlled data suggest, in a moderately advanced HIV population, a better CD4 cell recovery for lopinavir-ritonavir than for efavirenz-treated patients, but a greater virological suppression in the efavirenz arm. efavirenz CD4 molecule Homo sapiens